Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Johnson and Johnson
Colorcon
Medtronic
Harvard Business School

Last Updated: May 21, 2022

Sumatriptan succinate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for sumatriptan succinate and what is the scope of patent protection?

Sumatriptan succinate is the generic ingredient in nine branded drugs marketed by Meridian Medcl, Glaxosmithkline, Antares Pharma Inc, Caplin, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Hikma, Mylan Labs Ltd, Par Pharm, Par Sterile Products, Sandoz Inc, Steriscience, Sun Pharm, Teva Parenteral, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Zydus, Endo Ventures Ltd, Currax, Upsher Smith Labs, Padagis Israel, Teva Branded Pharm, Aurobindo Pharma, Corepharma, Dr Reddys Labs Inc, Fosun Pharma, Hikma Pharms, Mylan, Orbion Pharms, Roxane, Sun Pharm Inds, Sun Pharm Inds Ltd, Teva, and Watson Labs, and is included in forty-one NDAs. There are thirty-eight patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Sumatriptan succinate has four hundred and twenty patent family members in thirty-one countries.

There are seventeen drug master file entries for sumatriptan succinate. Thirty-four suppliers are listed for this compound.

Drug Prices for sumatriptan succinate

See drug prices for sumatriptan succinate

Drug Sales Revenue Trends for sumatriptan succinate

See drug sales revenues for sumatriptan succinate

Recent Clinical Trials for sumatriptan succinate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The Second Hospital of Nanjing Medical UniversityPhase 3
The Affiliated Hospital of Qingdao UniversityPhase 3
West China HospitalPhase 3

See all sumatriptan succinate clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for sumatriptan succinate

US Patents and Regulatory Information for sumatriptan succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corepharma SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 200263-002 Jun 19, 2012 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-001 Jul 15, 2009 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Zydus SUMATRIPTAN SUCCINATE sumatriptan succinate INJECTABLE;SUBCUTANEOUS 090310-001 Aug 11, 2010 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Currax ONZETRA XSAIL sumatriptan succinate POWDER;NASAL 206099-001 Jan 27, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Teva Branded Pharm ZECUITY sumatriptan succinate SYSTEM;IONTOPHORESIS 202278-001 Jan 17, 2013 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Watson Labs SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 076933-002 Aug 10, 2009 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Glaxosmithkline IMITREX STATDOSE sumatriptan succinate INJECTABLE;SUBCUTANEOUS 020080-002 Feb 1, 2006 AB RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for sumatriptan succinate

International Patents for sumatriptan succinate

Country Patent Number Title Estimated Expiration
Portugal 1161274 See Plans and Pricing
United Kingdom 201000325 See Plans and Pricing
European Patent Office 3331524 See Plans and Pricing
Denmark 1555038 See Plans and Pricing
Israel 238603 See Plans and Pricing
Spain 2612830 See Plans and Pricing
World Intellectual Property Organization (WIPO) 02068030 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Medtronic
Dow
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.